Isis Pharmaceuticals, Inc. - Financial and Strategic Analysis Review

Summary

Isis Pharmaceuticals, Inc. - Financial and Strategic Analysis Review

Isis Pharmaceuticals (ISIS) is a biopharmaceutical company engaged in discovery and development of exciting new class antisense drugs for the treatment of a broad range of diseases by using its patented ribonucleic acid (RNA)-based drug discovery technologies. The company has a pipeline of around 20 antisense drugs in clinical and preclinical development. The company is headquartered at Carlsbad in California, United States

Global Markets Direct's Isis Pharmaceuticals, Inc. - Financial and Strategic Analysis Review is an in-depth business, strategic and financial analysis of Isis Pharmaceuticals, Inc.. The report provides a comprehensive insight into the company, including business structure and operations, executive biographies and key competitors. The hallmark of the report is the detailed strategic analysis of the company. This highlights its strengths and weaknesses and the opportunities and threats it faces going forward.

Scope

• Provides key company information for business intelligence needs.
• The company's strengths and weaknesses and areas of development or decline are analyzed. Financial, strategic and operational factors are considered.
• The opportunities open to the company are considered and its growth potential assessed. Competitive or technological threats are highlighted.
• The report contains critical company information - business structure and operations, the company history, major products and services, key competitors, key employees and executive biographies, different locations and important subsidiaries.
• The report provides detailed financial ratios for the past five years as well as interim ratios for the last four quarters.
• Financial ratios include profitability, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Reasons to buy

• A quick "one-stop-shop" to understand the company.
• Enhance business/sales activities by understanding customers' businesses better.
• Get detailed information and financial and strategic analysis on companies operating in your industry.
• Identify prospective partners and suppliers - with key data on their businesses and locations.
• Capitalize on competitor's weaknesses and target the market opportunities available to them.
• Compare your company's financial trends with those of your peers / competitors.
• Scout for potential acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

Contents

• List of Tables
• List of Figures
  • Key Facts
  • Business Description
  • Major Products and Services
  • History
  • SWOT Analysis
  • SWOT Analysis - Overview
  • Isis Pharmaceuticals, Inc. - Strengths
  • Isis Pharmaceuticals, Inc. - Strengths - Intellectual Property
  • Isis Pharmaceuticals, Inc. - Strengths - Antisense Technology
  • Isis Pharmaceuticals, Inc. - Strengths - Strategic Collaborations
  • Isis Pharmaceuticals, Inc. - Weaknesses
  • Isis Pharmaceuticals, Inc. - Weaknesses - Limited Manufacturing Facilities
  • Isis Pharmaceuticals, Inc. - Weaknesses - Dependence on Third Parties for Clinical Trials
  • Isis Pharmaceuticals, Inc. - Opportunities
  • Isis Pharmaceuticals, Inc. - Opportunities - Diversified Product Pipeline
  • Isis Pharmaceuticals, Inc. - Opportunities - Sale of IBIS
  • Isis Pharmaceuticals, Inc. - Opportunities - Changing Demographics
  • Isis Pharmaceuticals, Inc. - Threats
  • Isis Pharmaceuticals, Inc. - Threats - Increased Pricing Control
  • Isis Pharmaceuticals, Inc. - Threats - Changing Political Climate in the US
  • Isis Pharmaceuticals, Inc. - Threats - Tightening of the FDA's Regulatory Oversight
  • Isis Pharmaceuticals, Inc. - Threats - Emergence of Biogenerics / Biosimilars
  • Key Competitors
  • Key Employees
  • Key Employee Biographies
  • Company Statement
  • Locations And Subsidiaries
  • Locations And Subsidiaries - Head Office
  • Locations And Subsidiaries - Other Locations & Subsidiaries
  • Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
• Appendix
  • Methodology
  • Ratio Definitions
  • About Global Markets Direct
  • Contact Us
  • Disclaimer
• List of Tables
  • Isis Pharmaceuticals, Inc., Key Facts
  • Major Products and Services
  • Isis Pharmaceuticals, Inc., History
  • Isis Pharmaceuticals, Inc., Key Employees
  • Isis Pharmaceuticals, Inc., Key Employee Biographies
  • Isis Pharmaceuticals, Inc., Subsidiaries
  • Isis Pharmaceuticals, Inc., Ratios based on current share price
  • Isis Pharmaceuticals, Inc., Annual Ratios
  • Isis Pharmaceuticals, Inc., Interim Ratios
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
• List of Figures
  • Isis Pharmaceuticals, Inc., Ratio Charts